References

• Bertucci F, Finetti P, Rougemont J, (et al). (2004) Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy. Cancer Res 64:8558-8565, 2004 https://www.ncbi.nlm.nih.gov/pubmed/15574762
• Bruckman JE, Harris JR, Levene MB, Chaffey JT, Hellman S. Results of treating stage III carcinoma of the breast by primary radiation therapy. Cancer 1979, 43:985-993. http://onlinelibrary.wiley.com/doi/10.1002/1097-0142(197903)43:3%3C985::AID-CNCR2820430330%3E3.0.CO;2-1/full
• Chia S, Swain SM, Byrd DR, Mankoff DA. (2008) Locally advanced and inflammatory breast cancer. J Clin Oncol 2008;26(5):786–9. http://ascopubs.org/doi/abs/10.1200/jco.2008.15.0243
• Dawood S, Merajver SD, Viens P Vermeulen PB, Swain SM Buchholz TA. Dirix LY. (2011) International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment Ann Oncol (2011) 22 (3): 515-523. https://academic.oup.com/annonc/article/22/3/515/257813/International-expert-panel-on-inflammatory-breast
• Eubank WB, Mankoff DA (2005) Evolving role of positron emission tomography in breast cancer imaging. Semin Nucl Med 35:84-99, 2005 https://www.ncbi.nlm.nih.gov/pubmed/15765372
• Giordano SH, Hortobagyi GN (2003). Inflammatory breast cancer: clinical progress and the main problems that must be addressed. Breast Cancer Research 5 (6): 284–8 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC314400/
• Gonzalez-Angulo AM, Hennessy BT, Broglio K, Meric-Bernstam F, Cristofanilli M, Giordano SH, (et al). (2007) Trends for inflammatory breast cancer: is survival improving? Oncologist 2007;12(8):904–12.  http://theoncologist.alphamedpress.org/content/12/8/904
• Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH. (2005) Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst 2005;97(13):966–75.
• Kaufman M. (2000) Review of known prognostic variables. Results Probl Cell Differ 2000 , 140:77-87. https://www.ncbi.nlm.nih.gov/pubmed/8787079
• Kleer CG, van Golen KL, Merajver SD. (2000) Molecular biology of breast cancer metastasis: Inflammatory breast cancer—Clinical syndrome and molecular determinants. Breast Cancer Res 2:423-429, 2000 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138665/
• Levine PH, Veneroso C. (2008) The epidemiology of inflammatory breast cancer. Semin Oncol 2008;35(1):11–6. https://www.ncbi.nlm.nih.gov/pubmed/18308141
• Le-Petross CH, Bidaut L, Yang WT. (2008) Evolving role of imaging modalities in inflammatory breast cancer. Semin Oncol 2008;35(1):51–63. https://www.ncbi.nlm.nih.gov/pubmed/18308146
• Low JA, Berman AW, Steinberg SM, Danforth DN, Lippman ME, Swain SM. (2004) Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. J Clin Oncol 2004;22(20):4067–74 https://www.ncbi.nlm.nih.gov/pubmed/15483018
• Molckovsky, A, Fitzgerald B, Freedman O, Heisey R, Clemons M. (2009) Approach to inflammatory breast cancer. Can Fam Physician Vol. 55, No. 1, January 2009, pp.25 – 31. http://rjmp.com.ro/articles/2009.2/PM_Nr-2_2009_Art-08.pdf
• Parkin DM, Bray F, Ferlay J, (et al). (2002) Global cancer statistics 2002. CA Cancer J Clin 55:74-108, 2005 https://www.ncbi.nlm.nih.gov/pubmed/15761078
• Singletary SE, Cristofanilli M. (2008) Defining the clinical diagnosis of inflammatory breast cancer. Semin Oncol 2008;35(1):7–10. https://www.ncbi.nlm.nih.gov/pubmed/18308140
• Stocks LH, Patternson FM. (1976) Inflammatory carcinoma of the breast. Surg Gynecol Obstet 1976 , 143:885-889.
• Treves N: The inoperability of inflammatory carcinoma of the breast. Surg Gynecol Obstet 109:24-242, 1959
• Ueno NT, Buzdar AU, Singletary SE, (et al). (1997) Combined modality treatment of inflammatory breast carcinoma: Twenty years of experience at M. D. Anderson Cancer Center. Cancer Chemother Pharmacol 40:321-329, 1997  https://link.springer.com/article/10.1007/s002800050664
• Wingo PA. (2004) Population-based statistics for women with inflammatory breast cancer (United States). Cancer Causes and Control 15 (2004): 321-28 https://link.springer.com/article/10.1023/B:CACO.0000024222.61114.18
• Zucali R, Uslenghi C, Kenda R, Bonadonna G. (1976) Natural history of survival of inoperable breast cancer treated with radiotherapy and radiotherapy followed by radical mastectomy. Cancer. 1976 Mar;37(3):1422-31. https://www.ncbi.nlm.nih.gov/pubmed/816452